Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the fight against PF.

Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough energy ...

During the dog days of summer, columnist Sam Kirton takes special care to protect himself from medication side effects.

In CORAL, 165 IPF patients were given one of three doses of nalbuphine ER to test its ability to reduce cough frequency after six weeks.

Columnist Sam Kirton, calling the PF world an inclusive community, promotes care for those LGBTQIA+ while appealing to them to donate organs.

Let-7, an established tumor suppressor microRNA, plays a key role in lung tissue repair and the development of scarring, a study found.

A Phase 2 clinical trial has begun recruiting that’s assessing the safety and efficacy of LTI-03, Rein Therapeutics’ inhaled therapy for idiopathic pulmonary fibrosis (IPF). RENEW (NCT06968845) is ...

A committee of the European Medicines Agency (EMA) is recommending orphan drug status — a designation that aims to speed therapy development in rare diseases — for tranilast, the active ingredient in ...